Efficacy of 5 Years of Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B Patients With High Viral Load (HBV DNA ≥9 Log10 Copies/Ml)

被引：0
|
作者：
Gordon, Stuart C.
Marcellin, Patrick
Krastev, Zahary
Horban, Andrzej
Petersen, Joerg
Sperl, Jan
Phillip Dinh
Martins, Eduardo B.
Yee, Leland J.
Flaherty, John F.
Kitrinos, Kathryn M.
Rustgi, Nika Berger Vinod K.
Heathcote, Jenny
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S954 / S954
页数：1
相关论文
共 50 条
  • [21] Tenofovir Disoproxil Fumarate (TDF) Versus Emtricitabine Plus TDF (FTC/TDF) for Treatment of Chronic Hepatitis B (CHB) in Patients with Persistent Viral Replication Receiving Adefovir Dipivoxil
    Berg, Thomas
    Moeller, Bernd
    Trinh, Huy N.
    Chan, Sing
    Marcellin, Patrick
    Suarez, Emilio
    Snow-Lampart, Andrea
    Oldach, David W.
    Sorbel, Jeff
    Borroto-Esoda, Katyna
    Frederick, David
    Rousseau, Franck
    GASTROENTEROLOGY, 2009, 136 (05) : A799 - A799
  • [22] CLINICAL, VIROLOGICAL, SEROLOGICAL AND HISTOLOGICAL OUTCOMES IN CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR UP TO 5 YEARS
    Buti, M.
    Fung, S.
    Gane, E.
    Afdhal, N.
    Flaherty, J.
    Martins, E.
    Bekele, N.
    Bornstein, J.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S197 - S198
  • [23] Clinical, virological, serological and histological outcomes in cirrhotic patients with chronic hepatitis B (CHB) treated with tenofovir disoproxil fumarate (TDF) for up to 5 years
    Sievert, William
    Strasser, Simone
    Gane, Ed
    George, Jacob
    Weilert, Frank
    Elsome, Amanda M.
    Flaherty, John F.
    Martins, Eduardo
    Bekele, Neby
    Bornstein, Jeffrey D.
    Buti, Maria
    Marcellin, Patrick
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 179 - 180
  • [24] TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL
    Berg, T.
    Moller, B.
    Trinh, H.
    Chan, S.
    Marcellin, P.
    Suarcz, E.
    Snow-Lampart, A.
    Oldach, D.
    Sorbel, J.
    Borroto-Esoda, K.
    Frederick, D.
    Rousseau, F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S328 - S328
  • [25] 1 YEAR SAFETY AND EFFICACY DATA IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TENOFOVIR DISOPROXIL FUMARATE (TDF) AFTER SWITCHING FROM TDF TO TENOFOVIR ALAFENAMIDE (TAF)
    Pan, Calvin Q.
    Gane, Edward
    Seto, Wai-Kay
    Janssen, Harry L.
    Caruntu, Florin
    Kim, Hyung Joon
    Abdurakhmanov, Dzhamal
    Nishiguchi, Shuhei
    Bae, Ho
    Mo, Shuyuan
    Suri, Vithika
    Gaggar, Anuj
    Flaherty, John F.
    Kao, Jia-Horng
    Brunetto, Maurizia Rossana
    Buti, Maria
    GASTROENTEROLOGY, 2018, 154 (06) : S1132 - S1133
  • [26] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) AT 96 WEEKS IN CHRONIC HBV (CHB) PATIENTS WITH RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Chan, Henry Lik-Yuen
    Buti, Maria
    Flisiak, Robert
    Ryder, Stephen
    Streinu-Cercel, Adrian
    Flaherty, John F.
    Gaggar, Anuj
    Mo, Shuyuan
    Subramanian, G. Mani
    Zoulim, Fabrian
    Andreone, Pietro
    Marcellin, Patrick
    GUT, 2018, 67 : A97 - A97
  • [27] Circulating Tregs Correlate with Viral Load Reduction in Chronic HBV-Treated Patients with Tenofovir Disoproxil Fumarate
    Nirupma TrehanPati
    Shyam Kotillil
    Syed S. Hissar
    Shikha Shrivastava
    Arshi Khanam
    Sukriti Sukriti
    Siddartha K. Mishra
    Shiv Kumar Sarin
    Journal of Clinical Immunology, 2011, 31 : 509 - 520
  • [28] Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load
    Wang, Ming
    Ran, Ran
    Zhu, Yunxia
    Zhang, Hua
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 160 (02) : 646 - 652
  • [29] SAFETY AND EFFICACY AT 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TDF USE
    Buti, Maria
    Lampertico, Pietro
    Lim, Young-Suk
    Agarwal, Kosh
    Fung, Scott K.
    Tsang, Owen
    Elkhashab, Magdy
    Kao, Jia-Horng
    Luis Calleja, Jose
    Khalili, Mandana
    Ravendhran, Natarajan
    Tan, Susanna
    Flaherty, John F.
    Gaggar, Anuj
    Lau, Audrey H.
    Wu, George
    Hann, Hie-Won L.
    Pan, Calvin
    Kim, Hyung Joon
    Kennedy, Patrick T. F.
    Chan, Henry Lik Yuen
    HEPATOLOGY, 2019, 70 : 301A - 301A
  • [30] AN EFFICACY OF CONTINUING TENOFOVIR DISOPROXIL FUMARATE VERSUS SWITCHING ENTECAVIR TO TENOFOVIR DISOPROXIL FUMARATE IN TREATMENT OF CHRONIC HEPATITIS B PATIENTS: 5-YEAR FOLLOW UP
    Ungtrakul, Teerapat
    Chiersilpa, Kunsuda
    Yingcharoen, Kesinee
    Jiraphairot, Suppawat
    Sangwipasnapaporn, Worrawat
    Dechma, Jiraporn
    Chunnuan, Pitchayachuda
    Kusuman, Pattama
    Pothijaroen, Charinthip
    Tawpa, Jantarika
    Hankla, Pimprapa
    Numahan, Apichayaporn
    Pongpun, Wanwisa
    Soonklang, Kamonwan
    GUT, 2022, 71 : A72 - A72
12345